Picture of Consun Pharmaceutical logo

1681 — Consun Pharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: Consun Pharmaceutical announces further acquisition of about 5.42% equity interest in Guangxi Yulin Pharmaceutical

Aug 16 (Reuters) - Consun Pharmaceutical Group Ltd  1681.HK : 
 
 * Connected transaction - further acquisition of approximately 5.42% equity interest in Guangxi Yulin Pharmaceutical Group Co., Ltd.  1681.HK  
 * Unit has entered into the equity transfer agreements with the seventh round vendors on 15 August 2016 and 16 August 2016 
 * Says consideration to be funded by internal resources of the group 
 * Deal for consideration of approximately RMB47.3 million 
 
* Source text for Eikon  urn:newsml:reuters.com:*:nHKS376KzP 
 
((Further company coverage:  1681.HK )) 
((Bangalore.newsroom@thomsonreuters.com))

Recent news on Consun Pharmaceutical

See all news